These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 9006889)
1. Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. Gether U; Ballesteros JA; Seifert R; Sanders-Bush E; Weinstein H; Kobilka BK J Biol Chem; 1997 Jan; 272(5):2587-90. PubMed ID: 9006889 [TBL] [Abstract][Full Text] [Related]
2. Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes. Gether U; Lin S; Kobilka BK J Biol Chem; 1995 Nov; 270(47):28268-75. PubMed ID: 7499324 [TBL] [Abstract][Full Text] [Related]
3. Examination of ligand-induced conformational changes in the beta 2-adrenergic receptor by fluorescence spectroscopy. Kobilka BK; Gether U Adv Pharmacol; 1998; 42():470-3. PubMed ID: 9327941 [No Abstract] [Full Text] [Related]
4. Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta 2 adrenergic receptor mapped by site-selective fluorescent labeling. Jensen AD; Guarnieri F; Rasmussen SG; Asmar F; Ballesteros JA; Gether U J Biol Chem; 2001 Mar; 276(12):9279-90. PubMed ID: 11118431 [TBL] [Abstract][Full Text] [Related]
5. Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor. Gether U; Lin S; Ghanouni P; Ballesteros JA; Weinstein H; Kobilka BK EMBO J; 1997 Nov; 16(22):6737-47. PubMed ID: 9362488 [TBL] [Abstract][Full Text] [Related]
6. c-Src tyrosine kinase binds the beta 2-adrenergic receptor via phospho-Tyr-350, phosphorylates G-protein-linked receptor kinase 2, and mediates agonist-induced receptor desensitization. Fan G; Shumay E; Malbon CC; Wang H J Biol Chem; 2001 Apr; 276(16):13240-7. PubMed ID: 11278940 [TBL] [Abstract][Full Text] [Related]
7. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes. Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579 [TBL] [Abstract][Full Text] [Related]
9. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. Hebert TE; Moffett S; Morello JP; Loisel TP; Bichet DG; Barret C; Bouvier M J Biol Chem; 1996 Jul; 271(27):16384-92. PubMed ID: 8663163 [TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of the beta2 adrenergic receptor alters the orientation of its sixth membrane-spanning segment. Javitch JA; Fu D; Liapakis G; Chen J J Biol Chem; 1997 Jul; 272(30):18546-9. PubMed ID: 9228019 [TBL] [Abstract][Full Text] [Related]
11. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations. Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949 [TBL] [Abstract][Full Text] [Related]
12. Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states. Swaminath G; Xiang Y; Lee TW; Steenhuis J; Parnot C; Kobilka BK J Biol Chem; 2004 Jan; 279(1):686-91. PubMed ID: 14559905 [TBL] [Abstract][Full Text] [Related]
13. Treatment with inverse agonists enhances baseline atrial contractility in transgenic mice with chronic beta2-adrenoceptor activation. Nagaraja S; Iyer S; Liu X; Eichberg J; Bond RA Br J Pharmacol; 1999 Jul; 127(5):1099-104. PubMed ID: 10455254 [TBL] [Abstract][Full Text] [Related]
14. Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. Rasmussen SG; Jensen AD; Liapakis G; Ghanouni P; Javitch JA; Gether U Mol Pharmacol; 1999 Jul; 56(1):175-84. PubMed ID: 10385699 [TBL] [Abstract][Full Text] [Related]
15. Identification of a conserved switch residue responsible for selective constitutive activation of the beta2-adrenergic receptor. Zuscik MJ; Porter JE; Gaivin R; Perez DM J Biol Chem; 1998 Feb; 273(6):3401-7. PubMed ID: 9452461 [TBL] [Abstract][Full Text] [Related]
16. Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor. Chidiac P; Nouet S; Bouvier M Mol Pharmacol; 1996 Sep; 50(3):662-9. PubMed ID: 8794908 [TBL] [Abstract][Full Text] [Related]
17. Site-specific fluorescence labeling of the beta2 adrenergic receptor amino terminus. Parola AL; Lin S; Kobilka BK Anal Biochem; 1997 Dec; 254(1):88-95. PubMed ID: 9398350 [TBL] [Abstract][Full Text] [Related]
18. Activation of the beta(2)-adrenergic receptor-Galpha(s) complex leads to rapid depalmitoylation and inhibition of repalmitoylation of both the receptor and Galpha(s). Loisel TP; Ansanay H; Adam L; Marullo S; Seifert R; Lagacé M; Bouvier M J Biol Chem; 1999 Oct; 274(43):31014-9. PubMed ID: 10521499 [TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor. Goetz A; Lanig H; Gmeiner P; Clark T J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586 [TBL] [Abstract][Full Text] [Related]
20. Examination of ligand-induced conformational changes in the beta2 adrenergic receptor. Kobilka B; Gether U; Seifert R; Lin S; Ghanouni P Life Sci; 1998; 62(17-18):1509-12. PubMed ID: 9585127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]